[27P2-pm2] Clinical Pharmacy 3

[27P2-pm2-111] Analysis of the Safety and Infusion Time after the Revision of Rituximab Treatment Protocol for Outpatients

○Sakurai Hiroomi¹, Okumura Yohei¹, Kasai Yusuke¹, Nonomiya Saya¹, Yoshida Kana¹, Tsuda Soichiro¹, Muramatsu Hiroshi¹, Aomori Toru^1,2, Ohtani Hisakazu^1,2,3 (1. Keio Univ. Fac. Pharm., 2. Keio Univ. Hosp. Dep. Pharm., 3. Keio Univ. Sch. Med.)